J. Mendlewicz

发表

EEG sleep studies in patients with generalized anxiety disorder

G. Papadimitriou, M. Kerkhofs, C. Kempenaers, 1988, Psychiatry Research.

Automated sleep scoring: a comparative reliability study of two algorithms.

M. Kerkhofs, J. Mendlewicz, E. Stanus, 1987, Electroencephalography and clinical neurophysiology.

Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex

J. Mendlewicz, D. Wikler, P. Damhaut, 1997, British Journal of Psychiatry.

Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder.

P. Visscher, S. Cichon, N. Freimer, 2003, American journal of human genetics.

5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder

P. Verbanck, Y. Lecrubier, S. Kasper, 2010, International clinical psychopharmacology.

Frontal and parietal metabolic disturbances in unipolar depression

André Luxen, Serge Goldman, Julien Mendlewicz, 1994, Biological Psychiatry.

Gender differences in depression

J. Lépine, J. Mendlewicz, A. Gamma, 2002, European Archives of Psychiatry and Clinical Neuroscience.

Working Memory-Related Functional Brain Patterns in Never Medicated Children with ADHD

Philippe Peigneux, Martin Kavec, Julien Mendlewicz, 2012, PloS one.

Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.

Julien Mendlewicz, Siegfried Kasper, Koen Demyttenaere, 2007, The Journal of clinical psychiatry.

Consensus Document on European Brain Research

J. Olesen, R. Corradetti, J. Mendlewicz, 2011, The European journal of neuroscience.

European combined analysis of the CTG18.1 and the ERDA1 CAG/CTG repeats in bipolar disorder

D. Blackwood, W. Muir, C. Broeckhoven, 2002, European Journal of Human Genetics.

Consensus document on European brain research.

J. Olesen, J. Mendlewicz, M. di Luca, 2006, Journal of neurology, neurosurgery, and psychiatry.

A double‐blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders

J. Mendlewicz, J. Peuskens, F. Lotstra, 1990, Acta psychiatrica Scandinavica. Supplementum.

Letter: How blind is the double-blind?: an assessment in a lithium-prophylaxis study.

R. Fieve, J. Mendlewicz, F. Stallone, 1974, Lancet.

Life Events and Primary Affective Disorders

J. Mendlewicz, L. Staner, M. Dramaix, 1996, British Journal of Psychiatry.

Effects of intravenous catheter on sleep in healthy men and in depressed patients.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1989, Sleep.

Failure to Replicate Influence of GRIK4 and GNB3 Polymorphisms on Treatment Outcome in Major Depression

A. Serretti, Y. Lecrubier, S. Kasper, 2012, Neuropsychobiology.

The age factor in depressive illness: some genetic considerations.

J. Mendlewicz, 1976, Journal of gerontology.

Guidelines for depot antipsychotic treatment in schizophrenia

J. Guelfi, E. Lindström, J. Mendlewicz, 1998, European Neuropsychopharmacology.

Reduced Cholecystokinin Levels in Cerebrospinal Fluid of Parkinsonian and Schizophrenic Patients Effect of Ceruletide in Schizophrenia a

P. Verbanck, J. Mendlewicz, J. Vanderhaeghen, 1985, Annals of the New York Academy of Sciences.

Linkage studies with X-chromosome markers in bipolar (manic-depressive) and unipolar (depressive) illnesses.

J. Fleiss, J. Mendlewicz, 1974, Biological psychiatry.

Identification of a CACNA2D4 deletion in late onset bipolar disorder patients and implications for the involvement of voltage‐dependent calcium channels in psychiatric disorders

D. Grozeva, N. Craddock, E. Green, 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes.

C. Broeckhoven, J. Mendlewicz, D. Souery, 1996, American journal of medical genetics.

Family study of panic disorder: comparison with generalized anxiety disorder, major depression and normal subjects

G. Papadimitriou, J. Mendlewicz, J. Wilmotte, 1993 .

Neurologic soft signs in borderline personality disorder.

J. Bobes, J. Mendlewicz, J. M. De la Fuente, 2006, The Journal of clinical psychiatry.

Effects of Early Treatment of Poststroke Depression on Neuropsychological Rehabilitation

J. Mendlewicz, A. Lobo, J. L. González-Torrecillas, 1995, International Psychogeriatrics.

Effect of an antidiencephalon immune serum on pain and sleep in primary fibromyalgia.

C. Kempenaers, J. Mendlewicz, V. De Maertelaer, 1994, Neuropsychobiology.

Lack of association between the 5HT2A receptor polymorphism (T102C) and unipolar affective disorder in a multicentric European study

R. Kaneva, A. Serretti, C. Broeckhoven, 2003, European Neuropsychopharmacology.

Transcriptional profiles underlying vulnerability and resilience in rats exposed to an acute unavoidable stress

F. Ferrari, J. Mendlewicz, E. Tagliafico, 2012, Journal of Neuroscience Research.

HLA antigens in affective disorders and schizophrenia.

P. Verbanck, P. Linkowski, J. Mendlewicz, 1981, Journal of affective disorders.

HLA Antigens in Affective Disorders

P. Verbanck, P. Linkowski, J. Mendlewicz, 1979 .

Alterations in Circadian Secretion of Pituitary and Pineal Hormones in Affective Disorders

J. Mendlewicz, 1986 .

Circadian changes in pituitary hormone levels in manic-depressive illness

J. Mendlewicz, 1980 .

PRIMARY ENURESIS AND AFFECTIVE ILLNESS

J. Mendlewicz, J. Klotz, 1974 .

The GABAergic Hypothesis of Mood Disorders

G. Papadimitriou, J. Mendlewicz, D. Souery, 2000 .

Temporal glucose metabolism in borderline personality disorder

A. Luxen, L. Bidaut, J. Mendlewicz, 1994, Psychiatry Research: Neuroimaging.

Tyrosine hydroxylase polymorphism and phenotypic heterogeneity in bipolar affective disorder: a multicenter association study.

R. Kaneva, A. Serretti, Marina Heiden, 1999, American journal of medical genetics.

Bipolar manic depressive illness and the fragile X syndrome

J. Mendlewicz, D. Hirsch, 1991, Biological Psychiatry.

HLA ANTIGENS AND SCHIZOPHRENIA

P. Linkowski, J. Mendlewicz, 1980, The Lancet.

Simultaneous study of 24-hour patterns of melatonin and cortisol secretion in depressed patients.

P. Linkowski, J. Mendlewicz, U. Weinberg, 1982, Neuropsychobiology.

Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders

J. Mendlewicz, J. Wybran, S. Legros, 2004, European archives of psychiatry and neurological sciences.

Genetic control of 24-hour growth hormone secretion in man: a twin study.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1999, The Journal of clinical endocrinology and metabolism.

Genetic and environmental influences on prolactin secretion during wake and during sleep.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1998, American journal of physiology. Endocrinology and metabolism.

Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders.

P. Verbanck, P. Linkowski, J. Mendlewicz, 1984, Life sciences.

5-HT2 receptor antagonism and slow-wave sleep in major depression.

C. Kempenaers, J. Mendlewicz, L. Staner, 1992, Acta psychiatrica Scandinavica.

Immediate and delayed alterations of adrenocorticotropin and cortisol nyctohemeral profiles after corticotropin-releasing factor in normal man.

P. Linkowski, J. Mendlewicz, D. Désir, 1983, The Journal of clinical endocrinology and metabolism.

Thyrotrophin response to thyrotrophin-releasing hormone in unipolar and bipolar affective illness.

P. Linkowski, J. Mendlewicz, H. Brauman, 1981, Journal of affective disorders.

Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients

A. Serretti, J. Mendlewicz, D. Souery, 2014, Journal of Neural Transmission.

Letter: Primary enuresis and affective illness.

J. Mendlewicz, J. Klotz, 1974, Lancet.

The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs.

D. Rujescu, A. Serretti, L. Bartova, 2022, Journal of Affective Disorders.

The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries

D. Rujescu, A. Serretti, L. Bartova, 2022, European Archives of Psychiatry and Clinical Neuroscience.

Relationship between schizoaffective illness and affective disorders or schizophrenia. Morbidity risk and genetic transmission.

P. Linkowski, J. Mendlewicz, J. Wilmotte, 1980, Journal of affective disorders.

Double-blind procedure: an assessment in a study of lithium prophylaxis

R. Fieve, J. Mendlewicz, F. Stallone, 1975, Psychological Medicine.

A novel CpG-associated brain-expressed candidate gene for chromosome 18q-linked bipolar disorder

P. D. Rijk, C. Broeckhoven, S. Claes, 2002, Molecular Psychiatry.

Lack of genetic association between the phospholipase A2 gene and bipolar mood disorder in a European multicentre case–control study

S. Cichon, M. Rietschel, M. Nöthen, 2006, Psychiatric genetics.

Drug repositioning for treatment-resistant depression: insights from a pharmacogenomic study

Albani, D. Rujescu, A. Serretti, 2020 .

The Impact of Adverse Life Events on Clinical Features and Interaction with Gene Variants in Mood Disorder Patients

A. Serretti, S. Kasper, J. Mendlewicz, 2013, Psychopathology.

Patient-control association study of substance P-related genes in unipolar and bipolar affective disorders.

S. Claes, J. Mendlewicz, D. Souery, 2005, The international journal of neuropsychopharmacology.

Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients

A. Serretti, S. Kasper, J. Mendlewicz, 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.

M. Rietschel, A. Farmer, P. McGuffin, 2011, The Journal of clinical psychiatry.

Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders.

L. Peltonen, R. Kaneva, A. Serretti, 2002, American journal of medical genetics.

No association between bipolar affective disorder and a serotonin receptor (5-HT2A) polymorphism

C. Broeckhoven, J. Mendlewicz, D. Souery, 1997, Psychiatry Research.

The search for a manic depressive gene: from classical to molecular genetics.

J. Mendlewicz, 1994, Progress in brain research.

Plasma and urinary cortisol levels after dexamethasone in affective disorders.

J. Mendlewicz, J. Meunier, Yves Léonce Mardens, 1981, Journal of affective disorders.

relationship to suicidal behaviour Thyrotrophin response to thyreostimulin in affectively ill women

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 2011 .

Suicide on the paternal and maternal sides of depressed patients with a lifetime history of attempted suicide

P. Linkowski, G. Papadimitriou, J. Mendlewicz, 1991, Acta psychiatrica Scandinavica.

Thyrotropin Response to Thyreostimulin and Suicidal Behaviour

P. Linkowski, J. Mendlewicz, J. P. V. Wettere, 1985 .

Thyrotrophin Response to Thyreostimulin in Affectively Ill Women Relationship to Suicidal Behaviour

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1983, British Journal of Psychiatry.

Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment.

S Kasper, M Lader, M. Stein, 2000, Journal of affective disorders.

Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy.

J. Guelfi, W. Gaebel, E. Lindström, 1998, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.

The 24 hour pattern of plasma melatonin in depressed patients before and after treatment.

P. Linkowski, J. Mendlewicz, E. Weitzman, 1980, Communications in psychopharmacology.

J. Mendlewicz, 1991, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

Biological Rhythms and Mood Disorders

P. Linkowski, J. Mendlewicz, 1988 .

Characterisation of medication side effects in patients with mostly resistant depression in a real-world setting

D. Rujescu, A. Serretti, S. Kasper, 2022, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression.

A. Serretti, L. Bartova, S. Kasper, 2021, Journal of psychiatric research.

Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients.

A. Serretti, S. Kasper, J. Mendlewicz, 2013, Journal of affective disorders.

Efficacy, safety, and indications for tricyclic and newer antidepressants

A. Rush, J. Lépine, S. Kasper, 1994 .

Mirtazapine is more effective than trazodone: a double‐blind controlled study in hospitalized patients with major depression

J. Mendlewicz, J. Wilde, J. Wilmotte, 1995, International clinical psychopharmacology.

Biological markers as classifiers for depression: A multivariate study

P. Linkowski, J. Mendlewicz, L. Staner, 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Relationship between the effectiveness of lithium therapy and family history.

R. Fieve, J. Mendlewicz, F. Stallone, 1973, The American journal of psychiatry.

Social adjustment and the course of affective illness: A one‐year controlled longitudinal study involving bipolar and unipolar outpatients

J. Mendlewicz, L. Staner, M. Dramaix, 1998, Depression and anxiety.

Antidepressant side effects and adverse reactions

S. Kasper, J. Mendlewicz, G. Beaumont, 1994 .

Biological nature of depressive symptoms in borderline personality disorder: endocrine comparison to recurrent brief and major depression.

J. Bobes, J. Mendlewicz, J. M. De la Fuente, 2002, Journal of psychiatric research.

Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patterns.

D. Rujescu, A. Serretti, S. Kasper, 2022, Journal of affective disorders.

Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression.

A. Serretti, L. Bartova, S. Kasper, 2019, The Journal of clinical psychiatry.

Growth hormone release after desipramine in depressive illness

M. Kerkhofs, J. Mendlewicz, C. Decoster, 2004, European archives of psychiatry and neurological sciences.

Biological factors in affective disorders and their relevance to lithium prophylaxis.

J. Mendlewicz, 1982, Pharmacopsychiatria.

Immigration and psychopathology: a clinical study

J. Mendlewicz, F. Bauwens, G. Stefos, 1995, European Psychiatry.

No evidence of antipsychotic effect of caerulein in schizophrenic patients free of neuroleptics: a double-blind cross-over study.

P. Verbanck, J. Mendlewicz, J. Vanderhaeghen, 1984, Biological psychiatry.

Increased neurophysin I and II cerebrospinal fluid concentrations from bipolar versus unipolar depressed patients.

P. Linkowski, J. Mendlewicz, V. Geenen, 1983 .

The Dexamethasone Suppression Test in Affective Disorder

J. Mendlewicz, G. Charles, J. M. Franckson, 1982, British Journal of Psychiatry.

Nonlinkage of bipolar illness to tyrosine hydroxylase, tyrosinase, and D2 and D4 dopamine receptor genes on chromosome 11.

C. Broeckhoven, J. Mendlewicz, L. Sandkuijl, 1994, The American journal of psychiatry.

Clonidine-induced growth hormone secretion in elderly patients with senile dementia of the alzheimer type and major depressive disorder

J. Mendlewicz, C. Gilles, Pierre Ryckaert, 1989, Psychiatry Research.

ACTH, cortisol and growth hormone 24-hour profiles in major depressive illness.

P. Linkowski, J. Mendlewicz, E. van Cauter, 1985, Acta psychiatrica Belgica.

Life events and the dexamethasone suppression test in affective illness.

P. Linkowski, J. Mendlewicz, F. Charon, 1986, Journal of affective disorders.

Biological Correlates of Suicide

P. Linkowski, J. Mendlewicz, 1983 .

TRH stimulation and dexamethasone suppression in borderline personality disorder

J. Mendlewicz, J. D. L. Fuente, 1996, Biological Psychiatry.

THYROTROPHIN, PROLACTIN AND GROWTH HORMONE RESPONSES TO TRH IN BARBITURATE COMA AND IN DEPRESSION

P. Linkowski, J. Mendlewicz, M. L'hermite, 1978, Clinical endocrinology.

The dexamethasone suppression test in affective illnesses and schizophrenia: relationship with psychotic symptoms.

J. Mendlewicz, M. Simonnet, P. Hubain, 1986, Neuropsychobiology.

The dexamethasone suppression test and cerebral blood flow in primary major depression.

J. Mendlewicz, J. Jacquy, J. Wilmotte, 1983, Biological psychiatry.

Self-esteem, social adjustment and suicidality in affective disorders

C. Stefanis, G. Papadimitriou, J. Mendlewicz, 2002, European Psychiatry.

Regional Cerebral Blood Flow in Patients with Affective Disorders

J. Mendlewicz, V. De Maertelaer, V. Delvenne, 1990, British Journal of Psychiatry.

Short-term and long-term treatment for bipolar patients: beyond the guidelines.

J. Mendlewicz, D. Souery, S. Rivelli, 1999, Journal of affective disorders.

[Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].

J. Mendlewicz, F. Lotstra, J. Bier, 2003, L'Encephale.

Measuring depression: comparison and integration of three scales in the GENDEP study

M. Rietschel, A. Elkin, A. Farmer, 2007, Psychological Medicine.

Prophylactic Use of Anticholinergics in Patients on Long-Term Neuroleptic Treatment

S. Potkin, W. Bunney, M. Maj, 1990, British Journal of Psychiatry.

Molecular genetics of aﬀective disorders

J. Mendlewicz, D. Souery, P. Oswald, 2003 .

Excess tyrosine hydroxylase restriction fragment length polymorphism homozygosity in unipolar but not bipolar patients: A preliminary report

C. Broeckhoven, J. Mendlewicz, D. Souery, 1996, Biological Psychiatry.

State-dependent tardive dyskinesia in manic-depressive illness.

P. Linkowski, J. Mendlewicz, R. D. de Potter, 1983, Journal of neurology, neurosurgery, and psychiatry.

Molecular Genetic Approach in Affective Illness

J. Mendlewicz, 1990 .

Age at onset in bipolar-related major affective illness: clinical and genetic implications.

N. Risch, J. Mendlewicz, M. Baron, 1982, Journal of psychiatric research.

Predicting response: serotonin reuptake inhibition.

J. Mendlewicz, 1999, International clinical psychopharmacology.

Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression

D. Rujescu, C. Lewis, A. Serretti, 2020, medRxiv.

PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway

A. Serretti, S. Kasper, J. Mendlewicz, 2014, The Pharmacogenomics Journal.

Biological treatment of unipolar depressive disorders in the general practitioner's medical care: Guidelines of the World Federation of Societies of Biological Psychiatry (WFSBP)

Gheorghe, D. Kupfer, H. Möller, 2008 .

Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression

A. Serretti, S. Kasper, J. Mendlewicz, 2012, Neuroscience Letters.

Molecular genetics in the analysis of suicide

P. Linkowski, J. Mendlewicz, D. Souery, 2003, Annals of medicine.

Sleep-EEG in borderline patients without concomitant major depression: a comparison with major depressives and normal control subjects

J. Bobes, J. Mendlewicz, J. D. L. Fuente, 2001, Psychiatry Research.

Transmission of Manic-Depressive Illness

J. Fleiss, R. Fieve, J. Mendlewicz, 1973 .

HLA antigens and schizophrenia: A pool of two studies

J. Mendlewicz, W. Gattaz, H. Beckmann, 1981, Psychiatry Research.

Lack of association between GABRA3 and unipolar affective disorder: a multicentre study.

R. Kaneva, V. Milanova, G. Papadimitriou, 2001, The international journal of neuropsychopharmacology.

Social Adjustment of Remitted Bipolar and Unipolar Out-patients

J. Mendlewicz, D. Pardoen, F. Bauwens, 1991, British Journal of Psychiatry.

A Genetic Study of Plasma Dopamine ß-Hydroxylase in Affective Disorder

J. Mendlewicz, M. Levitt, 1975 .

HÆMODIALYSIS IN SCHIZOPHRENIA

P. Linkowski, J. Mendlewicz, J. Vanherweghem, 1979, The Lancet.

Differential fertility in bipolar affective illness.

N. Risch, J. Mendlewicz, M. Baron, 1982, Journal of affective disorders.

Genetic Studies in Schizoaffective Illness

J. Mendlewicz, 1977 .

Biological and clinical features of recurrent brief depression: a comparison with major depressed and healthy subjects.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1992, Journal of affective disorders.

Polysomnographic characteristics in recurrent brief depression: a comparative study with major depression and controls.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1992, Acta psychiatrica Belgica.

Manic-Depressive Illness: A Comparative Study of Patients with and Without a Family History

J. Fleiss, R. Fieve, J. Mendlewicz, 1972, British Journal of Psychiatry.

CONSENSUS DOCUMENT ON EUROPEAN BRAIN RESEARCH Chapter I : Brain development , plasticity and ageing in health and disease Section

J. Olesen, M. Luca, R. Corradetti, 2011 .

Treatment resistant depression: methodological overview and operational criteria

J. Amsterdam, C. Montigny, Y. Lecrubier, 1999, European Neuropsychopharmacology.

Switching Antidepressant Class Does Not Improve Response or Remission in Treatment-Resistant Depression

A. Serretti, Y. Lecrubier, S. Kasper, 2011, Journal of clinical psychopharmacology.

Pharmacologic profile and efficacy of venlafaxine

J. Mendlewicz, 1995, International clinical psychopharmacology.

The use of lithium in affective disorders. 3. A double-blind study of prophylaxis in bipolar illness.

R. Fieve, J. Mendlewicz, F. Stallone, 1973, The American journal of psychiatry.

The 24-hour profile of plasma prolactin in men with major endogenous depressive illness.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1989, Archives of general psychiatry.

Prolactin secretion in women with unipolar and bipolar depression

P. Linkowski, J. Mendlewicz, H. Brauman, 1980, Psychiatry Research.

GROWTH HORMONE AND PROLACTIN RESPONSE TO LEVODOPA IN AFFECTIVE ILLNESS

P. Linkowski, J. Mendlewicz, H. Brauman, 1977, The Lancet.

Haemodialysis in schizophrenia: a double blind study - preliminary report.

P. Linkowski, J. Mendlewicz, J. Vanherweghem, 1979, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Haloperidol plasma levels and clinical response in schizophrenia

P. Linkowski, J. Mendlewicz, A. Schoutens, 1981 .

Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samples

D. Rujescu, B. Penninx, A. Serretti, 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Twin study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1993, The American journal of physiology.

DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee.

J. Lépine, J. Mendlewicz, A. Tylee, 1999, International clinical psychopharmacology.

Genetic Research in Psychiatry

J. Mendlewicz, B. Bondy, M. Ackenheil, 1992, Springer Berlin Heidelberg.

Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas.

H. Akiskal, J. Mendlewicz, R. Howland, 1999, Journal of affective disorders.

International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets

L. Bartova, S. Kasper, J. Mendlewicz, 2018, Pharmacological Reviews.

The role of noradrenaline and selective noradrenaline reuptake inhibition in depression

E. Paykel, S. Kasper, J. Mendlewicz, 2002, European Neuropsychopharmacology.

in to

H. Praag, J. Mendlewicz, 2005 .

Reduced clonidine rapid eye movement sleep suppression in patients with primary major affective illness.

J. Mendlewicz, J. Wilmotte, R. Machowski, 1992, Archives of general psychiatry.

Adoption study supporting genetic transmission in manic–depressive illness

J. Mendlewicz, J. Rainer, 1977, Nature.

24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1987, The Journal of clinical endocrinology and metabolism.

Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples

A. Serretti, J. Mendlewicz, D. Souery, 2013, Journal of psychopharmacology.

The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness.

P. Linkowski, J. Mendlewicz, E. van Cauter, 1985, The Journal of clinical endocrinology and metabolism.

Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder

D. Rujescu, A. Serretti, S. Kasper, 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Rare copy number variants in neuropsychiatric disorders: Specific phenotype or not?

D. Blackwood, B. Pickard, J. Mendlewicz, 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Genetic refinement and physical mapping of a chromosome 18q candidate region for bipolar disorder

C. Broeckhoven, J. Mendlewicz, D. Souery, 1999, European Journal of Human Genetics.

Linkage analysis of families with bipolar illness and chromosome 18 markers

C. Broeckhoven, J. Mendlewicz, D. Souery, 1996, Biological Psychiatry.

Linkage analysis of bipolar illness with X-chromosome DNA markers: a susceptibility gene in Xq27-q28 cannot be excluded.

J. Mendlewicz, L. Sandkuijl, C. van Broeckhoven, 1994, American journal of medical genetics.

Linkage analysis of families with manic depressive illness with markers from chromosome X and 11

C. Broeckhoven, J. Mendlewicz, L. Sandkuijl, 1991 .

POLYMORPHIC DNA MARKER ON X CHROMOSOME AND MANIC DEPRESSION

J. Mendlewicz, S. Sevy, G. Vassart, 1987, The Lancet.

Absence of linkage between chromosome 11p15 markers and manic-depressive illness in a Belgian pedigree.

M. Leboyer, J. Mallet, A. Malafosse, 1991, The American journal of psychiatry.

Linkage between Glucose-6-Phosphate Dehydrogenase Deficiency and Manic-Depressive Psychosis

P. Linkowski, J. Mendlewicz, J. Wilmotte, 1980, British Journal of Psychiatry.

Molecular genetics of affective disorders

J. Mendlewicz, D. Souery, P. Oswald, 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Molecular genetics of affective disorders.

J. Mendlewicz, D. Souery, P. Oswald, 2003, The international journal of neuropsychopharmacology.

A collaborative study of genetic linkage of bipolar manic‐depressive illness and red/green colorblindness : A PROJECT OF THE BIOLOGICAL PSYCHIATRY COLLABORATIVE PROGRAM OF THE WORLD HEALTH ORGANIZATION

W. Bunney, E. Gershon, J. Mendlewicz, 1980, Acta psychiatrica Scandinavica.

Evidence for X-linkage in the transmission of manic-depressive illness.

J. Fleiss, R. Fieve, J. Mendlewicz, 1972, JAMA.

Minireview: Molecular genetics in affective illness.

J. Mendlewicz, S. Sevy, K. Mendelbaum, 1993, Life sciences.

Assessing the role of X-linked inheritance in bipolar-related major affective disorder.

N. Risch, J. Mendlewicz, M. Baron, 1986, Journal of psychiatric research.

Color blindness linkage to bipolar manic-depressive illness. New evidence.

P. Linkowski, J. Mendlewicz, H. V. van Praag, 1979, Archives of general psychiatry.

New Genetic Findings in Recurrent Mood Disorders

J. Mendlewicz, 1993 .

Molecular genetic studies in affective illness

J. Mendlewicz, 1991, European Neuropsychopharmacology.

Genetics of schizophrenia. A consensus paper of the WFSBP task force on genetics

D. Rujescu, S. Cichon, P. Muglia, 2016 .

New Genetic Strategies in Neuropsychiatric Disorders

J. Mendlewicz, 1990 .

Population and Family Studies in Depression and Mania

J. Mendlewicz, 1988, British Journal of Psychiatry.

Genetic association between the phospholipase A2 gene and unipolar affective disorder: a multicentre case–control study

S. Cichon, M. Rietschel, M. Nöthen, 2003, Psychiatric genetics.

Expanded trinucleotide CAG repeats in families with bipolar affective disorder

C. Broeckhoven, J. Mendlewicz, D. Souery, 1997, Biological Psychiatry.

X-Linked Inheritance in Affective Disorders

J. Mendlewicz, 1985 .

Morbidity Risks in Subtypes of Unipolar Depressive Illness: Differences Between Early and Late Onset Forms

J. Mendlewicz, M. Baron, 1981, British Journal of Psychiatry.

Linkage studies in affective disorders: the Xg blood group and manic-depressive illness.

J. Fleiss, R. Fieve, J. Mendlewicz, 1975, Proceedings of the annual meeting of the American Psychopathological Association.

Morbidity risk and genetic transmission in manic-depressive illness.

J. Mendlewicz, J. Rainer, 1974, American journal of human genetics.

Blood groups in manic-depressive illness and schizophrenia.

J. Fleiss, J. Mendlewicz, J. Wilmotte, 1974, Diseases of the nervous system.

Brain glucose metabolism in borderline personality disorder.

J. Bobes, J. Mendlewicz, E. Stanus, 1997, Journal of psychiatric research.

Detection of expanded CAG repeats in Bipolar Affective Disorder using the repeat expansion detection (RED) method

K. Lindblad, C. Broeckhoven, J. Mendlewicz, 1995, Neurobiology of Disease.

The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study

A. Serretti, S. Kasper, J. Mendlewicz, 2017, The international journal of neuropsychopharmacology.

Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression

A. Serretti, S. Kasper, J. Mendlewicz, 2015, The International journal of neuroscience.

The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk—a European multicentre study on treatment-resistant major depressive disorder

A. Serretti, S. Kasper, J. Mendlewicz, 2013, European Archives of Psychiatry and Clinical Neuroscience.

Molecular Interpretation of Expanded RED Products in Bipolar Disorder by CAG/CTG Repeats Located at Chromosomes 17q and 18q

K. Lindblad, C. Broeckhoven, J. Mendlewicz, 1999, Neurobiology of Disease.

Manic-depressive illness: linkage with the Xg blood group.

J. Fleiss, R. Fieve, J. Mendlewicz, 1973, The American journal of psychiatry.

Depression and Sleep Disorders: Clinical Relevance, Economic Burden and Pharmacological Treatment

I. Feinberg, P. Linkowski, B. Saletu, 2000, Neuropsychobiology.

European Group for the Study of Resistant Depression (GSRD) — Where have we gone so far: Review of clinical and genetic findings

A. Serretti, S. Kasper, J. Mendlewicz, 2012, European Neuropsychopharmacology.

Genetic variants associated with psychotic symptoms across psychiatric disorders

A. Serretti, L. Mandelli, S. Kasper, 2020, Neuroscience Letters.

Polygenic risk scores for neuropsychiatric, inflammatory, and cardio‐metabolic traits highlight possible genetic overlap with suicide attempt and treatment‐emergent suicidal ideation

D. Rujescu, A. Serretti, D. Wasserman, 2022, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Polygenic risk scores for psychiatric, inflammatory, and cardio-metabolic traits and diseases highlight possible genetic overlaps with suicide attempt and treatment-emergent suicidal ideation

D. Rujescu, A. Serretti, D. Wasserman, 2021, medRxiv.

Bipolar II disorder as a risk factor for postpartum depression.

A. Serretti, L. Mandelli, L. Bartova, 2016, Journal of affective disorders.

Posttraumatic Stress Disorder: Diagnosis and Epidemiology, Comorbidity and Social Consequences, Biology and Treatment

R. Kessler, J. Davidson, J. Mendlewicz, 2001, Neuropsychobiology.

Suicidal behaviour in major depressive illness

P. Linkowski, J. Mendlewicz, V. Maertelaer, 1985, Acta psychiatrica Scandinavica.

Clinical and genetic factors associated with suicide in mood disorder patients

A. Serretti, J. Mendlewicz, D. Souery, 2016, European Archives of Psychiatry and Clinical Neuroscience.

Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study

D. Rujescu, A. Serretti, S. Kasper, 2022, European Neuropsychopharmacology.

Depression in the community: the first pan‐European study DEPRES (Depression Research in European Society)

J. Lépine, J. Mendlewicz, A. Tylee, 1997, International clinical psychopharmacology.

Manic-depressive illness and linkage reanalysis in the Xq27-Xq28 region of chromosome X.

J. Mendlewicz, S. Sevy, D. Souery, 1995, Neuropsychobiology.

Noradrenaline in mood and anxiety disorders: basic and clinical studies

L. Judd, J. Mendlewicz, D. Souery, 2003, International clinical psychopharmacology.

Depression across mood disorders: review and analysis in a clinical sample.

A. Serretti, J. Mendlewicz, D. Souery, 2012, Comprehensive psychiatry.

Affective Disorder on Paternal and Maternal Sides

R. Fieve, J. Mendlewicz, J. Rainer, 1973, British Journal of Psychiatry.

Genetic and immunological factors in affective disorders and schizophrenia.

J. Mendlewicz, S. Sevy, 1986, Progress in brain research.

Comorbid hypertension in patients with major depressive disorder – Results from a European multicenter study

A. Serretti, L. Bartova, S. Kasper, 2019, European Neuropsychopharmacology.

Non‐replication of the brain‐derived neurotrophic factor (BDNF) association in bipolar affective disorder: A Belgian patient‐control study

S. Claes, J. Mendlewicz, D. Souery, 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives

D. Rujescu, A. Serretti, S. Kasper, 2018, The international journal of neuropsychopharmacology.

Clinical and psychosocial predictors of recurrence in recovered bipolar and unipolar depressives: a one-year controlled prospective study

J. Mendlewicz, L. Staner, M. Dramaix, 1997, Psychiatry Research.

Circadian and sleep-related endocrine rhythms in schizophrenia.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1991, Archives of general psychiatry.

Manic depressive disorder and chromosome 18

C. Broeckhoven, J. Mendlewicz, D. Souery, 1998 .

In search of anticipation in unipolar affective disorder

C. Broeckhoven, J. Mendlewicz, D. Souery, 2005, European Neuropsychopharmacology.

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case–control association study

S. Kasper, J. Mendlewicz, D. Souery, 2010, International clinical psychopharmacology.

Lack of association between HLA-DR antigens and sleep-onset REM periods in major depression

J. Mendlewicz, M. Andrien, E. Dupont, 1991, Biological Psychiatry.

Manic-depressive illness and HLA.

P. Verbanck, J. Mendlewicz, A. Govaerts, 2008, Tissue antigens.

The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder

D. Rujescu, A. Serretti, L. Bartova, 2021, The international journal of neuropsychopharmacology.

Accuracy of the family history method in affective illness. Comparison with direct interviews in family studies.

J. Fleiss, J. Mendlewicz, M. Cataldo, 1975, Archives of general psychiatry.

Cimetidine-induced mania.

J. Mendlewicz, J. Sobolski, P. Hubain, 1982, Neuropsychobiology.

Haloperidol plasma levels and clinical response in paranoid schizophrenics

P. Linkowski, J. Mendlewicz, P. Hubain, 2004, European archives of psychiatry and neurological sciences.

Age‐of‐onset and genetic transmission in affective disorders

J. Mendlewicz, M. Baron, J. Klotz, 1981, Acta psychiatrica Scandinavica.

Assortative mating in affective disorders.

R. Fieve, J. Mendlewicz, M. Baron, 1981, Journal of affective disorders.

Multiple-threshold transmission of affective disorders.

J. Mendlewicz, M. Baron, J. Rainer, 1981, Archives of general psychiatry.

Variation in GNB3 predicts response and adverse reactions to antidepressants

M. Rietschel, I. Craig, A. Elkin, 2011, Journal of psychopharmacology.

Changes in body weight during pharmacological treatment of depression.

M. Rietschel, A. Farmer, P. McGuffin, 2011, The international journal of neuropsychopharmacology.

Genetics of affective disorders. II. Morbidity risk and genetic transmission.

J. Mendlewicz, S. Gershon, B. Shopsin, 1976, Neuropsychobiology.

Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.

M. Rietschel, A. Farmer, P. McGuffin, 2011, Journal of affective disorders.

Recombinant DNA Studies of X Linkage in Affective Disorders

J. Mendlewicz, 1989 .

X-chromosome markers in bipolar illness.

J. Mendlewicz, 1981, Archives of general psychiatry.

Expanded RED products and loci containing CAG/CTG repeats on chromosome 17 (ERDA1) and chromosome 18 (CTG18.1) in trans‐generational pairs with bipolar affective disorder

K. Lindblad, J. Mendlewicz, D. Souery, 2004, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.

No evidence for the involvement of CAG/CTG repeats from within 18q21.33–q23 in bipolar disorder

C. Broeckhoven, S. Claes, J. Mendlewicz, 2000, European Journal of Human Genetics.

A linkage study between bipolar disorder and genes involved in dopaminergic and GABAergic neurotransmission

J. Mendlewicz, D. Souery, C. van Broeckhoven, 1996, Psychiatric genetics.

Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression

J. Mendlewicz, J. D. L. Fuente, 1992, Biological Psychiatry.

Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD)

A. Serretti, L. Bartova, S. Kasper, 2018, European Neuropsychopharmacology.

Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)

A. Serretti, L. Bartova, S. Kasper, 2018, The international journal of neuropsychopharmacology.

Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.

Riccardo Torta, Julien Mendlewicz, Hans-Jürgen Möller, 2002, The Journal of clinical psychiatry.

LITHIUM RATIO AND CLINICAL RESPONSE IN MANIC-DEPRESSIVE ILLNESS

J. Mendels, P. Verbanck, J. Mendlewicz, 1977, The Lancet.

Genetic aspects of affective illness

J. Mendlewicz, B. Shopsin, 1979 .

Genetic analysis of the 12Q candidate region for bipolar disorder

C. Broeckhoven, S. Claes, J. Mendlewicz, 1998 .

Genetics of Affective Disorders I

J. Mendlewicz, S. Gershon, B. Shopsin, 1976 .

Genetic mapping of manic-depressive illness.

J. Mendlewicz, 1991, Trends in genetics : TIG.

X-linkage in bipolar illness

C. Broeckhoven, J. Mendlewicz, A. D. Bruyn, 1991, Biological Psychiatry.

Pituitary and Pineal Hormone Rhythms in Manic-Depression

P. Linkowski, J. Mendlewicz, M. L'hermite, 1981 .

Thyrotropin nyctohemeral pattern in primary depression: differences between unipolar and bipolar women.

P. Linkowski, J. Mendlewicz, E. van Cauter, 1980, Life sciences.

Early detection of high risk subjects in affective disorders.

J. Mendlewicz, 1979, Progress in neuro-psychopharmacology.

A PHARMACOGENETIC APPROACH TO STUDY LITHIUM TREATMENT IN MANIC-DEPRESSIVE ILLNESS

P. Verbanck, J. Mendlewicz, 1978 .

Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance

A. Serretti, S. Kasper, J. Mendlewicz, 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Altered frontostriatal relationship in unmedicated schizophrenic patients

A. Luxen, J. Mendlewicz, S. Goldman, 1995, Psychiatry Research: Neuroimaging.

Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorder

C. Broeckhoven, S. Claes, J. Mendlewicz, 2007, Psychiatry Research.

Phenomenology of psychotic mood disorders: lifetime and major depressive episode features.

A. Serretti, S. Kasper, J. Mendlewicz, 2011, Journal of affective disorders.

Sleep EEG variables in young schizophrenic and depressive patients

P. Linkowski, M. Kerkhofs, C. Kempenaers, 1988, Biological Psychiatry.

Hemodialysis in schizophrenics. A double-blind study.

P. Linkowski, J. Mendlewicz, J. Vanherweghem, 1983, Archives of general psychiatry.

Efficacy of the 'clonidine REM suppression test (CREST)' to separate patients with major depression from controls; a comparison with three currently proposed biological markers of depression.

J. Mendlewicz, J. Wilmotte, R. Machowski, 1995, Journal of affective disorders.

Disruption of the Circadian Timing Systems

J. Mendlewicz, 2009, CNS drugs.

Treatment resistance in severe unipolar depression: no association with psychotic or melancholic features.

A. Serretti, S. Kasper, J. Mendlewicz, 2013, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder.

P. McGuffin, C. Lewis, W. Maier, 2012, Journal of Psychiatric Research.

Europe — Benelux Countries

J. Mendlewicz, 1988 .

The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes – Results from a cross-sectional European multicenter study

A. Serretti, L. Bartova, S. Kasper, 2017, European Neuropsychopharmacology.

Does sleep EEG data distinguish between UP, BPI or BPII major depressions? An age and gender controlled study.

P. Verbanck, P. Linkowski, M. Kerkhofs, 1998, Journal of affective disorders.

Detection of expanded CAG repeats in bipolar affective disorder using the repeat expansion detection method

K. Lindblad, C. Broeckhoven, J. Mendlewicz, 1995 .

A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping

D. Rujescu, C. Lewis, A. Serretti, 2019, Translational Psychiatry.

Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice

A. Serretti, L. Bartova, S. Kasper, 2019, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.

M. Rietschel, T. Schulze, A. Farmer, 2010, Journal of affective disorders.

Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance

A. Serretti, S. Kasper, J. Mendlewicz, 2017, European Archives of Psychiatry and Clinical Neuroscience.

History of suicide attempts among patients with depression in the GENDEP project.

M. Rietschel, A. Farmer, P. McGuffin, 2010, Journal of affective disorders.

Effects of Carbamazepine on Dexamethasone Suppression and Sleep Electroencephalography in Borderline Personality Disorder

J. Bobes, J. Mendlewicz, J. M. De la Fuente, 2002, Neuropsychobiology.

Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response

D. Rujescu, S. Cichon, P. Muglia, 2017, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples

D. Rujescu, C. Lewis, A. Serretti, 2018, British Journal of Psychiatry.

Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study.

A. Serretti, S. Kasper, J. Mendlewicz, 2016, Journal of affective disorders.

The broad spectrum of comorbid depression: implications for treatment

J. Mendlewicz, Julien Mendlewicz, 1998, European Psychiatry.

Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study

M. Rietschel, M. Nöthen, R. Kaneva, 2004, European Journal of Human Genetics.

Growth Hormone After Trh in Women with Depressive Illness

P. Linkowski, J. Mendlewicz, H. Brauman, 1980, British Journal of Psychiatry.

Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression

J. Mendlewicz, N. Brunello, C. Benatti, 2006, International clinical psychopharmacology.

Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients

A. Serretti, Y. Lecrubier, S. Kasper, 2009, International clinical psychopharmacology.

Critical issues in the treatment of affective disorders

D. Kupfer, C. Nemeroff, L. Judd, 1995 .

Mirtazapine, but not fluvoxamine, normalizes the blunted REM sleep response to clonidine in depressed patients: implications for subsensitivity of alpha2-adrenergic receptors in depression

J. Mendlewicz, J. Wilmotte, R. Machowski, 2002, Psychiatry Research.

Circadian variation of serum TSH in unipolar and bipolar depression

J. Mendlewicz, C. Kirkegaard, 1982, Psychiatry Research.

Neuronal cell adhesion genes and antidepressant response in three independent samples

A. Serretti, D. Gurwitz, S. Kasper, 2015, The Pharmacogenomics Journal.

Molecular changes associated with escitalopram response in a stress-based model of depression

J. Mendlewicz, N. Brunello, C. Benatti, 2018, Psychoneuroendocrinology.

Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study

D. Rujescu, C. Lewis, A. Serretti, 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Juvenile and late onset forms of depressive disorder: genetic and biological characterization of bipolar and unipolar illness-a review.

J. Mendlewicz, 1979, Maturitas.

What to expect from a third step in treatment resistant depression: A prospective open study on escitalopram

A. Serretti, S. Kasper, G. Papadimitriou, 2015, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression

Julien Mendlewicz, Siegfried Kasper, Alessandro Serretti, 2011, Psychiatry Research.

5‐HT2 receptor antagonism and slow‐wave sleep in major depression

C. Kempenaers, J. Mendlewicz, L. Staner, 1992 .

5-HT2a receptor polymorphism gene in bipolar disorder and harm avoidance personality trait.

F Hentges, J. Mendlewicz, D. Souery, 2000, American journal of medical genetics.

Association between the dopamine D3 receptor gene locus (DRD3) and unipolar affective disorder.

C. Stefanis, G. Papadimitriou, J. Mendlewicz, 1999, Psychiatric genetics.

Sex difference in 5HT2 receptor in the living human brain

Serge Goldman, Philippe Damhaut, David Wikler, 1996, Neuroscience Letters.

The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression

Pia Baldinger, Rupert Lanzenberger, Julien Mendlewicz, 2015, European Neuropsychopharmacology.

Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.

J. Mendlewicz, J. Vanderheyden, G. Noel, 1981, Neuropsychobiology.

Glucocorticoid Receptor Gene-Based SNP Analysis in Patients with Recurrent Major Depression

Julien Mendlewicz, Jurgen Del-Favero, Christine Van Broeckhoven, 2006, Neuropsychopharmacology.

Gender differences in depression

J. Lépine, J. Mendlewicz, A. Gamma, 2002, European Archives of Psychiatry and Clinical Neuroscience.

High occupational level is associated with poor response to the treatment of depression: A replication study

A. Serretti, L. Mandelli, S. Kasper, 2019, European Neuropsychopharmacology.

Time-dependent effects of escitalopram on brain derived neurotrophic factor (BDNF) and neuroplasticity related targets in the central nervous system of rats.

J. Mendlewicz, F. Caggia, N. Brunello, 2010, European journal of pharmacology.

Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.

A. Serretti, S. Kasper, J. Mendlewicz, 2018, Journal of affective disorders.

Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers – A pharmacoepidemiological cross-sectional multicenter study

A. Serretti, L. Bartova, U. Rabl, 2016, European Neuropsychopharmacology.

Social adjustment among treatment responder patients with mood disorders.

A. Serretti, S. Kasper, J. Mendlewicz, 2013, Journal of affective disorders.

PL01-01 - Genetic Reseach: Promises and Pitfalls for Clinical Treatment of Depression

J. Mendlewicz, 2011, European Psychiatry.

Towards achieving remission in the treatment of depression

J. Mendlewicz, 2008, Dialogues in clinical neuroscience.

Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression

A. Serretti, L. Bartova, S. Kasper, 2019, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression

A. Serretti, L. Bartova, S. Kasper, 2020, The international journal of neuropsychopharmacology.

Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomography

André Luxen, Serge Goldman, Julien Mendlewicz, 1994, European Journal of Nuclear Medicine.

Is the biological nature of depressive symptoms in borderline patients without concomitant Axis I pathology idiosyncratic? Sleep EEG comparison with recurrent brief, major depression and control subjects

P. Linkowski, J. Bobes, J. Mendlewicz, 2004, Psychiatry Research.

A. Serretti, L. Mandelli, L. Bartova, 2021, Depression and anxiety.

Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study.

A. Serretti, L. Bartova, S. Kasper, 2018, Journal of affective disorders.

Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study.

A. Serretti, L. Bartova, S. Kasper, 2017, Journal of psychiatric research.

The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment – a European multicentre study

A. Serretti, S. Kasper, J. Mendlewicz, 2016, International clinical psychopharmacology.

Identification of depressed patient types in the community and their treatment needs: findings from the DEPRES II (Depression Research in European Society II) survey. DEPRES Steering Committee.

J. Lépine, J. Mendlewicz, A. Tylee, 1999, International clinical psychopharmacology.

A double-blind comparison of tianeptine, imipramine and placebo in the treatment of major depressive episodes

J. Mendlewicz, H. Lôo, G. Cassano, 1996, European Psychiatry.

Citalopram versus desipramine in treatment resistant depression: Effect of continuation or switching strategies. A randomized open study

A. Serretti, S. Kasper, J. Mendlewicz, 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Diurnal hypersecretion of growth hormone in depression.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1985, The Journal of clinical endocrinology and metabolism.

Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample.

Rupert Lanzenberger, Julien Mendlewicz, Thomas Vanicek, 2017, The Journal of clinical psychiatry.

A New Prediction Model for Evaluating Treatment-Resistant Depression.

Rupert Lanzenberger, Julien Mendlewicz, Thomas Vanicek, 2017, The Journal of clinical psychiatry.

Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study

J. Mendlewicz, D. Souery, P. Oswald, 2006, International clinical psychopharmacology.

Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder

A. Serretti, S. Kasper, J. Mendlewicz, 2013, European Archives of Psychiatry and Clinical Neuroscience.

Some neuroendocrine parameters in bipolar and unipolar depression.

P. Linkowski, J. Mendlewicz, E. van Cauter, 1979, Journal of affective disorders.

24-Hour dopamine-beta-hydroxylase pattern: a possible biological index of manic-depression.

J. Mendlewicz, E. van Cauter, 1978, Life sciences.

The dexamethasone suppression test and sleep electroencephalogram in nonbipolar major depressed inpatients: A multivariate analysis

P. Linkowski, G. Papadimitriou, M. Kerkhofs, 1998, Biological Psychiatry.

Current concepts: I. The 24-hour profile of prolactin in depression.

P. Linkowski, J. Mendlewicz, E. van Cauter, 1980, Life sciences.

ABNORMAL 24 HOUR PATTERN OF MELATONIN SECRETION IN DEPRESSION

P. Linkowski, J. Mendlewicz, E. Weitzman, 1979, The Lancet.

[Biological aspects of suicide].

P. Linkowski, J. Mendlewicz, 1983, Acta psychiatrica Belgica.

Regional Cerebral Blood Flow and Lateralized Hemispheric Dysfunction in Depression

P. Linkowski, J. Mendlewicz, J. Jacquy, 1983, British Journal of Psychiatry.

Treatment-resistant mood disorders: The characterization and definition of treatment-resistant mood disorders

J. Mendlewicz, D. Souery, I. Massat, 2001 .

Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1995, Sleep.

A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response

D. Rujescu, A. Serretti, S. Kasper, 2021, European Neuropsychopharmacology.

Cell membrane anomaly in genetically determined manic-depressive illness.

P. Verbanck, J. Mendlewicz, 1981, Neuropsychobiology.

Lithium Accumulation in Erythrocytes of Manic-Depressive Patients: An in vivo Twin Study

P. Verbanck, P. Linkowski, J. Mendlewicz, 1978, British Journal of Psychiatry.

Genetics and Lithium Ion Metabolism in Affective Disorders

P. Verbanck, P. Linkowski, J. Mendlewicz, 1979 .

Genetics and psychopharmacology

J. Mendlewicz, 1975 .

Genetic history as a predictor of lithium response in manic-depressive illness.

J. Fleiss, R. Fieve, J. Mendlewicz, 1972, Lancet.

The serotonin transporter and the activity regulated cytoskeleton‐associated protein genes in antidepressant response and resistance: 5‐HTTLPR and other variants

A. Serretti, S. Kasper, J. Mendlewicz, 2018, Human psychopharmacology.

Sleep and neuroendocrine disturbances in catatonia. A case report.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1984, Journal of affective disorders.

Fluoxetine in Major Depression: Efficacy, Safety and Effects on Sleep Polygraphic Variables

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1990, International clinical psychopharmacology.

Sleep disturbances: Core symptoms of major depressive disorder rather than associated or comorbid disorders

J. Mendlewicz, 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Reduced prolactin release after thyrotropin-releasing hormone in manic depression.

P. Linkowski, J. Mendlewicz, H. Brauman, 1980, The New England journal of medicine.

Manic depressive illness and X chromosome

J. Mendlewicz, S. Sevy, S. Legros, 1991, The Lancet.

Attributional style and depression: a controlled comparison of remitted unipolar and bipolar patients.

J. Mendlewicz, D. Pardoen, F. Bauwens, 1992, British Journal of Clinical Psychology.

Cerebrospinal fluid neurophysins in affective illness and in schizophrenia

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 2004, European archives of psychiatry and neurological sciences.

Sleep polygraphic variables in anorexia nervosa and depression: a comparative study in adolescents.

M. Kerkhofs, J. Mendlewicz, V. Delvenne, 1990, Journal of affective disorders.

Speech Pause Time as a Method for the Evaluation of Psychomotor Retardation in Depressive Illness

J. Mendlewicz, J Mendlewicz, G M Hoffmann, 1985, British Journal of Psychiatry.

Behavioural and transcriptional effects of escitalopram in the chronic escape deficit model of depression

J. Mendlewicz, Francesco Gandolfi, N. Brunello, 2014, Behavioural Brain Research.

A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.

A. Serretti, Y. Lecrubier, S. Kasper, 2011, Journal of affective disorders.

Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study

D. Rujescu, G. Kranz, A. Serretti, 2018, Acta psychiatrica Scandinavica.

Response to Zhang et al. (2005) Loss-of-Function Mutation in Tryptophan Hydroxylase-2 Identified in Unipolar Major Depression. Neuron 45, 11–16

C. Broeckhoven, J. Mendlewicz, R. Adolfsson, 2005, Neuron.

Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: a multicenter association study

M. Nöthen, T. Schulze, C. Stefanis, 2001, Biological Psychiatry.

European Collaborative Project on Affective Disorders: interactions between genetic and psychosocial vulnerability factors

A. Serretti, Marina Heiden, D. Blackwood, 1998, Psychiatric Genetics.

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder

A. Serretti, L. Bartova, S. Kasper, 2018, Acta psychiatrica Scandinavica.

Violent suicidal behavior and the thyrotropin-releasing hormone-thyroid-stimulating hormone test: a clinical outcome study.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1984, Neuropsychobiology.

[French adaptation and validation of the Carroll rating scale for depression].

J. Mendlewicz, O. Frydman, J. Wilmotte, 1986, L'Encephale.

Depression in adolescents and young adults--polysomnographic and neuroendocrine aspects.

M. Kerkhofs, J. Mendlewicz, J. Appelboom-Fondu, 1988, Journal of affective disorders.

Basal Ganglia and Frontal Lobe Glucose Metabolism

A. Luxen, J. Mendlewicz, S. Goldman, 1995, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Opinion paper: poor response to treatment of depression in people in high occupational levels

A. Serretti, L. Mandelli, S. Kasper, 2018, Psychological Medicine.

New Molecular Genetic Studies in the Affective Disorders

J. Mendlewicz, 1992, Pharmacopsychiatry.

Current issues in bipolar disorder: A critical review

Y. Lecrubier, S. Kasper, J. Mendlewicz, 2007, European Neuropsychopharmacology.

Family history of major depression and residual symptoms in responder and non-responder depressed patients.

A. Serretti, S. Kasper, J. Mendlewicz, 2014, Comprehensive psychiatry.

The effects of antidepressant treatment on sleep disturbances in depression

M. Kerkhofs, J. Mendlewicz, 1995, European Psychiatry.

A Double-Blind Comparison of Dothiepin and Amitriptyline in Patients with Primary Affective Disorder: Serum Levels and Clinical Response

P. Linkowski, J. Mendlewicz, J. Rees, 1980, British Journal of Psychiatry.

Neuroendocrine and sleep variables in major depressed inpatients: role of severity

P. Linkowski, J. Mendlewicz, L. Staner, 1996, Psychiatry Research.

Dexamethasone resistance and cortisol secretion in depressive illness.

J. Mendlewicz, Yves Léonce Mardens, J. VandeWalle, 1983, Biological psychiatry.

Changes in sleep EEG architecture during the treatment of depressed patients with mianserin

G. Dunbar, J. Mendlewicz, G. Hoffman, 1985, Acta psychiatrica Scandinavica. Supplementum.

Perspectives and practical applications in psychopharmacogenetics.

J. Mendlewicz, 1979, Progress in neuro-psychopharmacology.

Psychosocial predictors of major affective recurrences in bipolar disorder: a 4‐year longitudinal study of patients on prophylactic treatment

J. Mendlewicz, L. Staner, D. Pardoen, 1996, Acta psychiatrica Scandinavica.

Interaction of Long-Term Antidepressant Treatment with Psychosocial Factors

J. Mendlewicz, D. Pardoen, F. Bauwens, 1996 .

Suicide by physicians.

J. Mendlewicz, J. Wilmotte, 1971, American Journal of Psychiatry.

Temperament and character influence on depression treatment outcome.

D. Rujescu, A. Serretti, S. Kasper, 2019, Journal of affective disorders.

Gene-based SNP genetic association study of the corticotropin-releasing hormone receptor-2 (CRHR2) in major depression.

S. Claes, J. Mendlewicz, D. Souery, 2002, American journal of medical genetics.

Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study

A. Serretti, L. Bartova, S. Kasper, 2020, European Neuropsychopharmacology.

[No hypofrontality in schizophrenia demonstrated by positron emission tomography].

A. Luxen, J. Mendlewicz, V. De Maertelaer, 1992, Acta psychiatrica Belgica.

Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder

Y. Lecrubier, S. Kasper, J. Mendlewicz, 2011, International clinical psychopharmacology.

Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study.

A. Serretti, L. Bartova, S. Kasper, 2021, Journal of affective disorders.

EEG sleep patterns in man: a twin study.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1989, Electroencephalography and clinical neurophysiology.

Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depression.

A. Serretti, S. Kasper, J. Mendlewicz, 2015, Journal of affective disorders.

Age as a moderating factor of treatment resistance in depression

D. Rujescu, A. Serretti, L. Bartova, 2023, European Psychiatry.

Body mass index and clinical outcomes in individuals with major depressive disorder: Findings from the GSRD European Multicenter Database.

A. Serretti, L. Bartova, S. Kasper, 2023, Journal of affective disorders.

PINEAL β-ADRENORECEPTOR DOWN-REGULATION BY DESIPRAMINE IN DEPRESSION

J. Mendlewicz, 1983, The Lancet.

A rhythmic movement disorder in REM sleep: a case report.

C. Kempenaers, J. Mendlewicz, E. Bouillon, 1994, Sleep.

Optimising antidepressant use in clinical practice: towards criteria for antidepressant selection

J. Mendlewicz, 2001, British Journal of Psychiatry.

Distribution of delta activity across nonrapid eye movement sleep episodes in healthy young men.

J. Lanquart, P. Linkowski, J. Mendlewicz, 1997, Sleep.

Pharmacogenetics of bipolar disorders

J. Mendlewicz, D. Souery, P. Oswald, 2006 .

High occupational level is associated with poor response to treatment of depression

A. Serretti, L. Mandelli, S. Kasper, 2016, European Neuropsychopharmacology.

Electroencephalogram and neuroendocrine parameters in pubertal and adolescent depressed children. A case report study.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1984, Journal of affective disorders.

Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study

A. Serretti, Y. Lecrubier, S. Kasper, 2010, International clinical psychopharmacology.

Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder

D. Rujescu, A. Serretti, L. Bartova, 2021, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Melancholic features in major depression – a European multicenter study

A. Serretti, L. Bartova, S. Kasper, 2021, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Sleep EEG and amitryptiline treatment in depressed inpatients

C. Kempenaers, J. Mendlewicz, V. Maertelaer, 1991, Biological Psychiatry.

Self-esteem in Recovered Bipolar and Unipolar Out-patients

J. Mendlewicz, D. Pardoen, F. Bauwens, 1993, British Journal of Psychiatry.

Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: Lack of association with clinical phenotypes

Y. Lecrubier, S. Kasper, J. Mendlewicz, 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Neuroendocrine and Clinical Characteristics of Major Depressed Patients Exhibiting Sleep-Onset REM

P. Linkowski, J. Mendlewicz, L. Staner, 1998, Biological Psychiatry.

familial factors in suicidal behaviour

P. Linkowski, G. Papadimitriou, J. Mendlewicz, 1988 .

Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study

A. Serretti, L. Bartova, S. Kasper, 2018, European Neuropsychopharmacology.

Further investigation of the dexamethasone suppression test in affective illnesses: relationship to clinical diagnosis and therapeutic response.

J. Mendlewicz, P. Hubain, C. Koumakis, 1984, Neuropsychobiology.

Genetic determinants of EEG sleep: a study in twins living apart.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1991, Electroencephalography and clinical neurophysiology.

Sleep EEG recordings in generalized anxiety disorder with significant depression.

P. Linkowski, G. Papadimitriou, M. Kerkhofs, 1988, Journal of affective disorders.

CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP

M. Rietschel, I. Craig, A. Farmer, 2012, Journal of psychopharmacology.

Effects of ECT on sleep and CSF biogenic amines in affective illness

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1985, Psychiatry Research.

Attrition in treatment-resistant depression: predictors and clinical impact.

A. Serretti, S. Kasper, J. Mendlewicz, 2019, International clinical psychopharmacology.

Reproducibility of the dexamethasone suppression test in depression.

J. Mendlewicz, J. Wilmotte, M. Quenon, 1982, Biological psychiatry.

Mirth and laughter arising from human temporal cortex

Steven Laureys, J. Mendlewicz, I. Massat, 2003, Journal of neurology, neurosurgery, and psychiatry.

The 24-hour profiles of cortisol, prolactin, and growth hormone secretion in mania.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1994, Archives of general psychiatry.

Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts

D. Rujescu, M. Kas, A. Serretti, 2021, International clinical psychopharmacology.

Seasonal variation in platelet 3H-imipramine binding in man

J. Mendlewicz, 1984, Psychiatry Research.

Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample

A. Serretti, S. Kasper, J. Mendlewicz, 2015, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.

Plasma levels of imipramine in depression. Environmental and genetic factors.

J. Mendlewicz, A. Glassman, J. Perel, 1976, Neuropsychobiology.

[Heredity and role of serotonin in aggressive impulsive behavior].

J. Mendlewicz, L. Staner, 1998, L'Encephale.

General anesthesia after neuroleptic malignant syndrome.

P. Linkowski, J. Mendlewicz, F. Lotstra, 1983, Biological psychiatry.

COMT and age at onset in mood disorders: A replication and extension study

A. Serretti, S. Kasper, J. Mendlewicz, 2011, Neuroscience Letters.

Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study

M. Rietschel, R. Kaneva, A. Serretti, 2005, Molecular Psychiatry.

REM sleep latency and morbidity risk of affective disorders in depressive illness.

J. Mendlewicz, S. Sevy, V. De Maertelaer, 1989, Neuropsychobiology.

Compliance and therapeutic issues in resistant depression

J. Mendlewicz, D. Souery, 1998, International clinical psychopharmacology.

Sleep Electroencephalography in Depressive Illness a Collaborative Study by the World Health Organization

M. Kerkhofs, J. Mendlewicz, 1991, British Journal of Psychiatry.

Responders and non-responders to lithium therapy. Some potential biological indicators.

J. Mendlewicz, 1981, Bibliotheca psychiatrica.

Familiality and SNP heritability of age at onset and episodicity in major depressive disorder

John P. Rice, M. Rietschel, M. Gill, 2015, Psychological Medicine.

Prolactin and growth hormone response to levodopa in affective illness.

P. Linkowski, J. Mendlewicz, H. Brauman, 1983, Neuropsychobiology.

WHO Pilot Study on the Validity of Imipramine Platelet Receptor Binding Sites as a Biological Marker of Endogenous Depression

J. Mendlewicz, P. Bech, P. Plenge, 1988, Pharmacopsychiatry.

A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression

C. Duijn, C. Broeckhoven, S. Claes, 2003, Molecular Psychiatry.

Gender differences in depression

J. Mendlewicz, A. Gamma, J. Angst, 2002, European Archives of Psychiatry and Clinical Neuroscience.

Social adjustment and self-esteem in remitted patients with mood disorders

A. Serretti, E. Smeraldi, J. Mendlewicz, 1999, European Psychiatry.

The Role of Relationship Status in Major Depressive Disorder - Results of the European Group for the Study of Resistant Depression.

A. Serretti, L. Mandelli, L. Bartova, 2021, Journal of affective disorders.

Brain glucose metabolism in eating disorders assessed by positron emission tomography.

A. Luxen, J. Mendlewicz, V. De Maertelaer, 1995, The International journal of eating disorders.

Regional cerebral blood flow in depressed patients

C. Stefanis, J. Mendlewicz, A. Rabavilas, 1990 .

Efficacy of tianeptine in the treatment of major depression and depressed bipolar disorders. Illustration of the interest of surveillance of a European multicentre double-blind study in progress: tianeptine versus placebo and imipramine

J. Mendlewicz, L. Staner, J. Mendlewicz, 1993, European Psychiatry.

LINKAGE ANALYSIS IN MANIC-DEPRESSIVE ILLNESS

J. Mendlewicz, B. Suarez, A. Wright, 1987, The Lancet.

Mixed, melancholic, and anxious features in depression: a cross-sectional study of sociodemographic and clinical correlates.

A. Serretti, S. Kasper, J. Mendlewicz, 2014, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Multivariate study of sleep EEG in depression

P. Linkowski, M. Kerkhofs, C. Kempenaers, 1988, Acta psychiatrica Scandinavica.

Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics

D. Rujescu, S. Cichon, P. Muglia, 2017, World Journal of Biological Psychiatry.

No implication of brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: Evidence from Belgian first and replication patient–control studies

C. Broeckhoven, S. Claes, J. Mendlewicz, 2005, European Neuropsychopharmacology.

Switching Antidepressant Class Does Not Improve Response or Remission in Treatment-Resistant Depression

A. Serretti, Y. Lecrubier, S. Kasper, 2011, Journal of clinical psychopharmacology.

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case–control association study

S. Kasper, J. Mendlewicz, D. Souery, 2010, International clinical psychopharmacology.

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part III: Maintenance Treatment

H. Akiskal, G. Goodwin, W. Nolen, 2004, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.

J. Mendlewicz, J. Vanderheyden, G. Noel, 1981, Advances in experimental medicine and biology.

Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder.

P. McGuffin, W. Maier, B. Muthén, 2012, Journal of psychiatric research.

[Analysis of intensity of post-stroke depression and its relationship with the cerebral lesion location].

J. Mendlewicz, A. Lobo, J. I. González Torrecillas, 1997, Medicina clinica.

The social burden of depressive disorders.

J. Mendlewicz, 1989, Neuropsychobiology.

New trends in suicide prevention

J. Mendlewicz, J. Wilmotte, 1982 .

Sleep EEG analysis by linear prediction: frequency changes of slow-wave activity within NREM and REM sleep episodes in healthy men.

J. Lanquart, P. Linkowski, M. Kerkhofs, 1996, Neuropsychobiology.

Antidepressant selection: Proceedings from a TCA/SSRI Consensus Conference

J. Mendlewicz, Y. Lecrubie, 2000, Acta psychiatrica Scandinavica. Supplementum.

Sleep spindle activity changes in patients with affective disorders.

V de Maertelaer, J. Mendlewicz, M. Lemaire, 1987, Sleep.

Introduction to the Special Section. New advances in the understanding and treatment of bipolar disorder.

J. Mendlewicz, D. Souery, 2003, The international journal of neuropsychopharmacology.

Sleep electroencephalogram and rhythm disturbances in mood disorders

P. Linkowski, J. Mendlewicz, 1993 .

5HT2 Receptor Antagonism and Slow Wave Sleep in Man

C. Kempenaers, J. Mendlewicz, L. Staner, 1990 .

Sleep EEG recordings in depressive disorders.

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1985, Journal of affective disorders.

Dexamethasone Suppression Test and REM Sleep in Patients with Major Depressive Disorder

P. Linkowski, M. Kerkhofs, J. Mendlewicz, 1984, British Journal of Psychiatry.

Excess of allele1 for α3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study

M. Rietschel, R. Kaneva, A. Serretti, 2002, Molecular Psychiatry.

Seasonal variations in the dexamethasone suppression test.

P. Linkowski, J. Mendlewicz, A. Coppen, 1987, Journal of affective disorders.

Affective disease health maintenance organization. Patterns of lithium response.

R. Fieve, J. Mendlewicz, E. Shelley, 1974, New York state journal of medicine.

Alprazolam and amitriptyline in the treatment of major depressive disorder: a double-blind clinical and sleep EEG study.

J. Mendlewicz, P. Mesters, P. Castro, 1990, Journal of affective disorders.

Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.

M. Rietschel, A. Farmer, P. McGuffin, 2011, Journal of affective disorders.

Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics

D. Rujescu, S. Cichon, P. Muglia, 2017, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Characteristics of spontaneous sleep with varying NREMS Episodes in healthy men: implication for delta activity homeostasis.

J. Lanquart, P. Linkowski, J. Mendlewicz, 2000, Sleep.